News - LGC acquires PolyDesign, a provider of innovative oligo solid support products for life sciences customers.
14 November 2023News - National Measurement Laboratory at LGC supports the UK global leadership in ensuring accurate diagnostics for future pandemics.
02 November 2023News - LGC Clinical Diagnostics, a business unit of LGC, today announced the acquisition of Virusys Corporation, a developer and manufacturer of monoclonal antibodies and viral antigens.
09 October 2023News - LGC announced today the appointment of David P. King as Non-Executive Chairman of its Board of Directors.
28 September 2023News - The UK National Reference Laboratory for GMOs based at LGC has reviewed the current state-of-the-art methods for the potential detection of Precision Bred Organisms (PBOs) in food and feed supply chains and to provide recommendations towards developing a framework for the traceability of PBOs.
18 September 2023News - Today, LGC Clinical Diagnostics, a business unit of LGC, announced the acquisition of Kova International, Inc. (Kova), a leading developer and manufacturer of in vitro urinalysis and toxicology quality control products for clinical laboratories
24 July 2023News - LGC today announced the appointment of Dr Mehrdad Tabrizi as Executive Vice President and General Manager for LGC Axolabs.
10 July 2023News - Five more soldiers who fell at the Battle of Fromelles more than 100 years ago have been identified using DNA analysis performed by LGC.
25 April 2023News - The first step in a partnership between the University of Leeds and the NML, the laboratory was launched on Friday, 31 March 2023 at a special event hosted Nexus, which features talks from Professors Julian Braybrook and Nick Plant, as well as a visit from the Mayor of West Yorkshire Tracy Brabin.
04 April 2023News - Leading manufacturer and supplier of analytical reference standards greatly complements LGC's current offering
22 March 2023